STEMCELL Technologies

whitepaper

Whitepaper: STEMdiff™ APEL™ Medium – Human PSC Differentiation to Multiple Lineages

31 October 2012 | By STEMCELL Technologies

STEMdiff™ APEL™ Medium is an animal component-free formulation that enables reliable differentiation of human ES cells and iPS cells. Developed by STEMCELL Technologies and based on a published formulation1, STEMdiff™ APEL™ Medium supports differentiation into ectoderm, mesoderm and endoderm lineages...

whitepaper

Whitepaper: Uniform and Scalable EB Formation for Drug Discovery and Regenerative Medicine Applications

1 June 2012 | By STEMCELL Technologies

The developmental versatility of pluripotent stem cells (PSCs) offers a powerful approach for directing cell fate, and these cells are a promising source of progenitors and terminally differentiated somatic cells for cell replacement therapy and drug screening applications.

whitepaper

Whitepaper: Increase the Physiological Relevance of HIV Models with RoboSep™

30 March 2012 | By STEMCELL Technologies

HIV research using human primary cells: despite intense research in the 30 years since the discovery of HIV/AIDS, the disease remains a global epidemic with no credible vaccine available.